poisar

Stock

SELLAS Life Sciences Group, Inc. SLS

$15.20+10.59%

Overview

SLS market data

Price History

SLS price chart · 1M
O
14.01
H
15.54
L
13.99
C
15.20
Vol
269,536.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$14.01
Previous Close
$13.75
Day High
$15.54
Day Low
$13.99
52 Week High
$15.86
52 Week Low
$4.66
7 Day Return
+13.43%
30 Day Return
+50.79%
90 Day Return
+63.35%
1 Year Return
+224.79%
Daily Notional Volume
$4.1M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.51
Diluted earnings per share over the trailing twelve months.
Beta
2.58
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-736.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$1.39 – $15.88
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $2.5B · P/B 7.58 · P/S 847.51.

Company News

10 captured
When Revolution Medicines' FDA Win Lifts Other Boats: SELLAS Life Sciences Stock SurgesBenzinga · Aug 27, 2026, 5:13 PM
Shares of mRNA cancer vaccine-related companies are trading higher amid sympathy with Merck and Moderna after they announced that intismeran autogene with KEYTRUDA yielded recurrence-free survival in patients with completely resected stage IIB-IV melanoma.Benzinga · Aug 19, 2026, 4:15 PM
SELLAS Life Sciences Gr Q2 EPS $(0.05) Misses $(0.04) EstimateBenzinga · Aug 11, 2026, 8:19 PM
SELLAS Says Arbitrator Dismisses Its Claims Against 3D Medicines, Orders SELLAS To Pay Approximately $1M In Legal FeesBenzinga · Jul 27, 2026, 8:42 PM
8-K filing — SELLAS Life Sciences Group, Inc. (SLS)SEC EDGAR · Jul 27, 2026, 8:35 PM
ManpowerGroup Posts Upbeat Q2 Earnings, Joins Docebo, Zentalis Pharmaceuticals And Other Big Stocks Moving Higher On FridayBenzinga · Jul 17, 2026, 2:09 PM
SELLAS Life Sciences Shares Slip Wednesday as Price Tests $16 Resistance WallBenzinga · Jul 8, 2026, 3:15 PM
SELLAS Life Sciences Shares Fall Tuesday: What's Driving The Move?Benzinga · Jun 30, 2026, 1:45 PM
Sellas Life Sciences Shares Break Out To New 52-Week High: What's Driving The Momentum?Benzinga · Jun 29, 2026, 8:10 PM
Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On MondayBenzinga · Jun 29, 2026, 2:00 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
SELLAS Life Sciences Group, Inc. (SLS) stock — price, valuation & news | Poisar